Topics

Companies Related to "Goodbye Strong Silent Type Hello Strong Expressive Type" [Most Relevant Company Matches] RSS

09:05 EST 16th December 2019 | BioPortfolio

Here are the most relevant search results for "Goodbye Strong Silent Type Hello Strong Expressive Type" found in our extensive corporate database of over 50,000 company records.

Showing "Goodbye Strong Silent Type Hello Strong Expressive Type" Companies 1–25 of 1,400+

Extremely Relevant

Glucox Biotech AB

The primary goal of Glucox Biotech is to develop a clinically applicable therapeutic drug for treatment of type 2 diabetes and insulin resistance. The highly favorable benefits of Glucox Biotech therapy is to decrease the critical risks and delay progression of the complications in Type 2 Diabetes patients by improving glycemic blood control. Based on its scientific excellence and with a strong mi...


Relevant

Betagenon AB

Betagenon has secured a strong, proprietary technology platform based upon the extensive research expertise on type 2 diabetes disease mechanisms established by the Founders, leading experts in the field. Betagenon's vision is to become a frontier company that delivers new smart drug platform solutions to the pharmaceutical industry for treatment of the metabolic syndrome and diabetes type 2. Afte...

Team Type 1 Foundation

Established in 2013, the Team Type 1 Foundation is a nonprofit organization pursuing a mission of education, empowerment and equal access to medicine for everyone affected by diabetes. Collaborating with governments, healthcare professionals, diabetes experts and individuals living with diabetes around the world, the Team Type 1 Foundation is bridging the ...


Tau Therapeutics LLC

Tau Therapeutics is a clinical stage company developing oncology drugs for solid tumors that selectively inhibit the T-type calcium channel – a novel mechanism of action for cancer. The company’s approach, called Interlaced Therapy™, capitalizes on the central role of calcium influx through T-type calcium channels during cancer cell growth. T-type ...

The T1D Exchange

The T1D Exchange is a unique platform for collaborative data collection and sharing that consists of three overlapping components: a clinic-based registry with clinical, biological and other real-life information from individuals with type 1 diabetes, a registry that is coordinated through a network of clinical centers and an interactive online community f...

Cavion LLC

Cavion LLC is a privately held clinical stage platform pharmaceutical company creating therapies engaging the T-type calcium channel (Cav3) for the treatment of neurologic and oncologic diseases. The T-type calcium channel is an emerging molecular target for cancer and pain.

T1D Exchange

T1D Exchange was founded on the belief that people affected by type 1 diabetes need better solutions faster – better treatments and better care. Our nonprofit organization takes an innovative approach that puts the community of people touched by type 1 diabetes at the center of research that will meaningfully impact their lives. Our integrated model ...

Ballantyne Strong, Inc.

http://www.strong-world.com (Investor Relations section) or www.earnings.com

Lauren's Hope Medical ID Bracelets

Founded in 2001, Lauren's Hope provides fashionable medical ID jewelry for men and women of all. Started when the cofounders' young friend, Lauren, refused to wear a medical ID tag for her type 1 diabetes because "they're ugly and draw attention to my illness," the company has been going strong ever since, with thousands of testimonials from customers who wear their jewelry with pride and have see...

BioMedical Research Models Incorporated (BRM)

Biomedical Research Models, Inc. (BRM) is a full service Contract Research Organization. We specialize in value added studies using our propriety model systems. BRM conducts studies on the efficacy of new drugs to improve Type 1 and Type 2 diabetes, diabetic complications, cancer, rheumatoid arthritis and auto-immune disease.

Diasome Pharmaceuticals, Inc.

Diasome Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity. Based on more than thirty years of research and development in the fields of cell receptor targeting, insulin formulation, and hepatic (liver) glucose metabolism, the companyâ€...

Point Therapeutics

Point Therapeutics, Inc is a Boston-based biopharmaceutical company dedicated to developing a family of dipeptidyl peptidase (DPP) inhibitors for use in cancer, type 2 diabetes and as vaccine adjuvants. DPPs are enzymes that appear to regulate several different physiological processes including those involved in tumor growth and host responses to cancer, type 2 diabetes, and immune responses to v...

DiObex

DiObex, Inc., a clinical-stage company based in San Francisco, is developing unique, first-in-class therapies for the critically under-served metabolic disease market. Our pipeline products address the markets for the treatment of type 1 diabetes, type 2 diabetes and its co-morbidities such as hypertension, dyslipidemia and visceral adiposity (often referred to collectively as “metabolic syndrom...

Veralox Therapeutics

VERALOX Therapeutics Inc. (https://veralox.com/) is developing first-in-class therapeutics that target the underlying pathologies of thrombosis and type 1 diabetes. The company’s lead candidate, VLX-1005, will be developed initially to treat patients with heparin-induced thrombocytopenia (HIT) and HIT with thrombosis (HITT). Second generation therapeutic products are under development for ty...

Exsulin Corporation

Based in Minneapolis, Exsulin Corporation has global rights to and pioneered the development of an experimental approach for the treatment of Type 1 and Type 2 diabetes with the goal of affecting the future of diabetes care and providing significant cost savings within the healthcare system. Exsulin has worked with leading research labs in multiple countries to develop the technology that has led ...

Creative Peptides develops pharmaceutical products

Creative Peptides develops pharmaceutical products based on C-peptide Our research will significantly improve on the treatment of long-term complications of type 1 diabetes. Complications of type 1 diabetes are currently not effectively and safely treatable and cause great suffering in afflicted patients as well as vast costs to society

University Louis Pasteur

ULP, with over 18.000 students, is distinctive for its scientific contributions which place it among the top-ranking French and European universities. This unique feature is reinforced by a strong and well-established collaboration with the CNRS and INSERM, and now with the INRA, and the interdisciplinary nature of its research. ULP progresses by exploring, for example, new scientific fields throu...

Delta Dental Plan of MA

Delta Dental provides group benefits for organizations ranging in size from five to 30,000 or more employees. Our customers come from every type of industry — from small software companies to international manufacturing firms.To meet our customers’ diverse needs, we’ve built three strong provider networks and offer a multitude of dental plans that can be customized to meet most companies’ ...

Glucose Health, Inc.

Glucose Health, Inc. dietary products engage the large and growing market of consumers aware of the seriousness of Type 2 diabetes and proactively seeking natural blood sugar health solutions. The CDC currently estimates 2 in 5 adults – 86 million Americans – will develop Type 2 diabetes in their lifetime. Glucose Health, Inc. dietary products ar...

Active Pass Pharmaceuticals

Active Pass' mission is to be the industry leader in the discovery and development of small-molecule drugs that target human ABC transporters. A family of 48 structurally-related molecular pumps, ABC transporters are targets for diseases with substantial markets including age-related macular degeneration, lipid disorders, Alzheimer's disease, and type II diabetes. Our competitive advantage derives...

Quantificare Inc.

Quantificare is a Central Laboratory providing analysis and management of Medical Images in phase I to IV pharmaceutical clinical trials. Operating as an independently owned company with a strong presence worldwide, Quantificare can handle every aspect related to medical images in large multi-center trials. The company has develop expertise allowing strict adherence to guidelines established by re...

ImmunoMolecular Therapeutics

IM Therapeutics is developing personalized immuno-therapeutic drugs for autoimmune diseases based on the genetic risk attributed by human leukocyte antigen genes. The lead candidate drug is an oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. Our goal is to preserve pancreatic beta cell fun...

CureDM, Inc.

CureDM, Inc., is a privately held, biopharmaceutical company focused on the discovery and development of new therapies that prevent, ameliorate, or reverse diseases of metabolism. CureDM is located in the Lankenau Institute for Medical Research (LIMR) at the Lankenau Hospital campus in Wynnewood, PA. CureDM has completed nearly all preclinical studies for ...

Team Type 1

Based in Atlanta, GA, Team Type 1 began as a grassroots initiative to motivate people to take control of their diabetes using cycling as a platform. It grew to become a world-class athletic program for all athletes with diabetes, including a professional men's cycling team, poised to compete at the 2012 Tour de France. Today, it is a global sports organiza...

Bristol-Myers Squibb Company

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.


More From BioPortfolio on "Goodbye Strong Silent Type Hello Strong Expressive Type"

Quick Search

Corporate Database Quicklinks